Discover a different approach to HER2-positive breast cancer treatment that’s designed to make part of your treatment faster.
Get help understanding your insurance coverage and assistance options.
Dig into the clinical trial results and see how PHESGO performed against PERJETA + Herceptin.
Review questions that you can ask your healthcare team about starting treatment with PHESGO.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.